Chun Peng
Yan-Ling Wang- 1Department of Biology and Centre for Research in Biomolecular Interactions, York University, Toronto, ON, Canada
- 2State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
Editorial on the Research Topic
MicroRNAs as New Players in Endocrinology
Endocrinology is the study of hormones. The term “hormone” was coined by Starling in 1905, based on the discovery of secretin (1). Hormones are traditionally defined as chemical messengers produced by endocrine glands (ductless glands) and enter circulation to regulate the activity of target organs at a distal site. However, not all hormones are produced from classical endocrine glands, and many chemical messengers exert their effects locally via autocrine/paracrine regulation. Therefore, endocrinology has become a science that deals more broadly with cell-cell communications and cellular signaling mechanisms (1). Hormones usually exert their functions by interacting with receptors located on the membrane or inside the cells to initiate signaling cascades, leading to changes in cellular activity (1).
MicroRNAs (miRNAs) are non-coding RNAs that play critical roles in gene expression (2, 3). In animal cells, microRNAs primarily regulate gene expression by binding to miRNA response elements, usually found at the 3′ UTR of target mRNAs, to decrease mRNA stability and induce translational repression (4, 5). It is now clear that miRNAs are crucial regulators of many developmental events and physiological processes. Several lines of evidence support the critical roles of miRNAs in the endocrine system.
First, miRNAs regulate hormone production, activity, and target cell responsiveness. miRNAs can directly target genes encoding hormones or enzymes involved in hormone production or metabolism, thereby affecting hormone concentrations. Proteins that modulate hormone actions, such as antagonists, can also be regulated by miRNAs. Furthermore, miRNAs target hormone receptors and intracellular signaling molecules to alter target cell responses. For example, we have shown that Nodal, a member of the transforming growth factor-β (TGF-β) superfamily, is targeted by miR-378a-5p (6). On the other hand, Nodal modulator1 (NOMO1), which is an antagonist of Nodal signaling, is a target of miR-675 (7). We have also identified several miRNAs that target Nodal receptors (8–10). Other members of the TGF-β family, as well as many other signaling pathways have also been reported to be regulated by miRNAs (11–17).
Second, many studies have demonstrated that miRNAs are regulated by hormones (18–20), and such regulation can occur at the level of transcription (21) or processing (22). For example, Interleukin 6 activates STAT3 to induce the transcription of miR-21 and miR-181-b1 genes (21). SMAD, which is activated by TGF-β signaling, regulates DROSHA-mediated miRNA maturation (22). Interestingly, the hormones-regulated miRNAs can be part of the feedback pathway to fine tune hormone activity. Thyroid hormone (TH) represses the transcription of miR-21, which in turn, downregulates the expression of GRHL3, a transcriptional inhibitor of type 3 iodothyronine deiodinase (D3). D3 inactivates TH, thereby terminating TH action (23).
Finally, miRNAs have been shown to have hormone-like activities and are important for intercellular communication. They can be secreted by host cells into extracellular fluids where they are either transported by vesicles, such as microvesicles and exosomes, or by forming complexes with proteins, especially AGO2 (24). These extracellular miRNAs can be taken up by recipient cells to regulate their activities. For example, it has been demonstrated that miRNAs produced from cardiac stem cells can be transferred, via gap junctions, to nearby cells and regulate target gene expression in the recipient cells (25). Thus, miRNAs may have endocrine, paracrine, and autocrine regulatory functions, similar to hormones (26). Interestingly, some miRNAs have been reported to bind to Toll-like receptors (TLR) and induce downstream signaling pathways (27). However, it remains to be determined if other miRceptors exist and what determines the specificity of miRNA-target cell interaction.
The Research Topic highlights some of the recent findings about miRNAs and their relationships with the endocrine system. O'Brien et al. provide an updated overview of miRNA biogenesis and mode of actions, as well as their circulation in the extracellular fluid. Park discusses the mechanisms of miRNA secretion via exocytosis and the functions of extracellular miRNAs in cellular signaling. Yusof et al. provide an example of miRNA expression in normal and cancerous thyroid gland. Tang et al. report findings from a primary study that elucidates how estrogen protects cardiomyocytes from oxidative stress via miR-494. Liu et al. present results that demonstrate miR-518b regulates MAPK signaling. Another study by Peng et al. shows that Interferon γ (IFNγ) induces miR-146a, which then regulates NFκB signaling. Neale et al. highlight the role of ghrelin in critical limb ischmia and the involvement of miRNAs in this process. Finally, Toms et al. summarize the interplay between ovarian miRNAs and steroid hormones in regulating the cyclic activity of the ovary.
Author Contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
Work performed in our labs have been supported by CIHR and NSFC.
References
2. Schier AF, Giraldez AJ. MicroRNA function and mechanism: insights from zebra fish. Cold Spring Harb Symp Quant Biol. (2006) 71:195–203. doi: 10.1101/sqb.2006.71.055
3. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. (2013) 14:475–88. doi: 10.1038/nrm3611
4. Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. (2015) 16:421–33. doi: 10.1038/nrg3965
5. Hayder H, O'brien J, Nadeem U, Peng C. MicroRNAs: crucial regulators of placental development. Reproduction (2018) 155:R259–71. doi: 10.1530/REP-17-0603
6. Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, et al. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci. (2012) 125:3124–32. doi: 10.1242/jcs.096412
7. Gao WL, Liu M, Yang Y, Yang H, Liao Q, Bai Y, et al. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). RNA Biol. (2012) 9:1002–10. doi: 10.4161/rna.20807
8. Bai Y, Yang W, Yang HX, Liao Q, Ye G, Fu G, et al. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS ONE (2012) 7:e38875. doi: 10.1371/journal.pone.0038875
9. Fu G, Ye G, Nadeem L, Ji L, Manchanda T, Wang Y, et al. MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension (2013) 61:864–72. doi: 10.1161/HYPERTENSIONAHA.111.203489
10. Wu H, Wang H, Liu M, Bai Y, Li YX, Ji L, et al. MiR-195 participates in the placental disorder of preeclampsia via targeting activin receptor type-2B in trophoblastic cells. J Hypertens. (2016) 34:1371–9. doi: 10.1097/HJH.0000000000000948
11. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. (2010) 11:252–63. doi: 10.1038/nrm2868
12. Onyido EK, Sweeney E, Nateri AS. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Mol Cancer (2016) 15:56. doi: 10.1186/s12943-016-0541-3
13. Sujitha S, Rasool M. MicroRNAs and bioactive compounds on TLR/MAPK signaling in rheumatoid arthritis. Clin Chim Acta (2017) 473:106–15. doi: 10.1016/j.cca.2017.08.021
14. Wang H, Gou X, Jiang T, Ouyang J. The effects of microRNAs on glucocorticoid responsiveness. J Cancer Res Clin Oncol. (2017) 143:1005–11. doi: 10.1007/s00432-017-2388-4
15. Zhang L, Li J, Wang Q, Meng G, Lv X, Zhou H, et al. The relationship between microRNAs and the STAT3-related signaling pathway in cancer. Tumour Biol. (2017) 39. doi: 10.1177/1010428317719869
16. Fattahi S, Pilehchian Langroudi M, Akhavan-Niaki H. Hedgehog signaling pathway: epigenetic regulation and role in disease and cancer development. J Cell Physiol. (2018) 233:5726–35. doi: 10.1002/jcp.26506
17. Wu J, Ding J, Yang J, Guo X, Zheng Y. MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer. Front Immunol. (2018) 9:546. doi: 10.3389/fimmu.2018.00546
18. Abramov R, Fu G, Zhang Y, Peng C. Expression and regulation of miR-17a and miR-430b in zebrafish ovarian follicles. Gen Comp Endocrinol. (2013) 188:309–15. doi: 10.1016/j.ygcen.2013.02.012
19. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, et al. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc Natl Acad Sci USA. (2014) 111:3008–13. doi: 10.1073/pnas.1318978111
20. Mcfall T, Mcknight B, Rosati R, Kim S, Huang Y, Viola-Villegas N, et al. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. J Biol Chem. (2018) 293:1163–77. doi: 10.1074/jbc.M117.812438
21. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell (2010) 39:493–506. doi: 10.1016/j.molcel.2010.07.023
22. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature (2008) 454:56–61. doi: 10.1038/nature07086
23. Di Girolamo D, Ambrosio R, De Stefano MA, Mancino G, Porcelli T, Luongo C, et al. Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis. J Clin Invest. (2016) 126:2308–20. doi: 10.1172/JCI84465
24. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. (2011) 39:7223–33. doi: 10.1093/nar/gkr254
25. Hosoda T, Zheng H, Cabral-Da-Silva M, Sanada F, Ide-Iwata N, Ogorek B, et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 123:1287–96. doi: 10.1161/CIRCULATIONAHA.110.982918
26. Fabbri M. MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philos Trans R Soc Lond B Biol Sci. (2018) 373. doi: 10.1098/rstb.2016.0486
Keywords: microRNA, cell signaling, endocrine system, hormone-like activity, miRceptor
Citation: Peng C and Wang Y-L (2018) Editorial: MicroRNAs as New Players in Endocrinology. Front. Endocrinol. 9:459. doi: 10.3389/fendo.2018.00459
Received: 20 July 2018; Accepted: 26 July 2018;
Published: 17 August 2018.
Edited and reviewed by: Cunming Duan, University of Michigan, United States
Copyright © 2018 Peng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chun Peng, cpeng@yorku.ca